Literature DB >> 10601699

Dietary docosahexaenoic acid ameliorates, but rapeseed oil and safflower oil accelerate renal injury in stroke-prone spontaneously hypertensive rats as compared with soybean oil, which is associated with expression for renal transforming growth factor-beta, fibronectin and renin.

M Miyazaki1, N Takemura, S Watanabe, N Hata, Y Misawa, H Okuyama.   

Abstract

We have noted that n-3 fatty acid-rich oils, such as fish oil, perilla oil and flaxseed oil as well as ethyl docosahexaenoate (DHA) prolonged the survival time of stroke-prone spontaneously hypertensive rats (SHRSP) rats by approximately 10% as compared with linoleate (n-6)-rich safflower oil. Rapeseed oil with a relatively low n-6/n-3 ratio unusually shortened the survival time by approximately 40%, suggesting the presence of minor components unfavorable to SHRSP rats. This study examined the effects of dietary oils and DHA on renal injury and gene expression related to renal injury in SHRSP rats. Rats fed rapeseed oil- and safflower oil-supplemented diets developed more severe proteinuria than those fed soybean oil-supplemented diet used as a control, but there were no significant differences in blood pressure. In contrast, the DHA-supplemented diet inhibited the development of proteinuria and suppressed hypertension. The mRNA levels for renal TGF-beta, fibronectin and renin were higher in the rapeseed oil and safflower oil groups after 9 weeks of feeding of the experimental diet than in the soybean oil and DHA groups. The fatty acid composition of kidney phospholipids was markedly affected by these diets. These results indicate that the renal injury observed in the groups fed safflower oil with a high n-6/n-3 ratio and rapeseed oil with presumed minor components is accompanied by increased expression of the TGF-beta, renin and fibronectin genes, and that dietary DHA suppresses renal injury and gene expression as compared with soybean oil.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601699     DOI: 10.1016/s1388-1981(99)00180-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Intakes of long-chain omega-3 polyunsaturated fatty acids and non-fried fish in relation to incidence of chronic kidney disease in young adults: a 25-year follow-up.

Authors:  Inwhee Park; Pengcheng Xun; Cari Lewis Tsinovoi; Philip Klemmer; Kiang Liu; Ka He
Journal:  Eur J Nutr       Date:  2019-06-07       Impact factor: 5.614

2.  Transforming growth factor beta in human milk does not change in response to modest intakes of docosahexaenoic acid.

Authors:  J S Hawkes; D L Bryan; M A Neumann; M Makrides; R A Gibson
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

3.  The Dietary Replacement of Soybean Oil by Canola Oil Does Not Prevent Liver Fatty Acid Accumulation and Liver Inflammation in Mice.

Authors:  Marina Masetto Antunes; Guilherme Godoy; Ingrid de Lima Fernandes; Luciana Pelissari Manin; Caroline Zappielo; Laureane Nunes Masi; Vivian Araújo Barbosa de Oliveira; Jesuí Vergílio Visentainer; Rui Curi; Roberto Barbosa Bazotte
Journal:  Nutrients       Date:  2020-11-28       Impact factor: 5.717

4.  Fully hydrogenated canola oil extends lifespan in stroke-prone spontaneously hypertensive rats.

Authors:  Kenjiro Tatematsu; Daisuke Miyazawa; Yoshiaki Saito; Harumi Okuyama; Naoki Ohara
Journal:  Lipids Health Dis       Date:  2021-09-12       Impact factor: 3.876

5.  Rapeseed (canola) oil aggravates metabolic syndrome-like conditions in male but not in female stroke-prone spontaneously hypertensive rats (SHRSP).

Authors:  Mai Nishikawa; Naoki Ohara; Yukiko Naito; Yoshiaki Saito; Chihiro Amma; Kenjiro Tatematsu; Jinhua Baoyindugurong; Daisuke Miyazawa; Yoko Hashimoto; Harumi Okuyama
Journal:  Toxicol Rep       Date:  2022-02-07

6.  Neuroprotective effect of docosahexaenoic acid nanoemulsion on erectile function in a rat model of bilateral cavernous nerve injury.

Authors:  Chun-Hou Liao; Yi-No Wu; Bin-Huei Chen; Ying-Hung Lin; Hsiu-O Ho; Han-Sun Chiang
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.